Showing 8,401 - 8,420 results of 18,313 for search 'significant ((((teer decrease) OR (((greatest decrease) OR (a decrease))))) OR (mean decrease))', query time: 0.76s Refine Results
  1. 8401

    Table3_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.DOC by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  2. 8402

    Image2_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.JPEG by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  3. 8403

    Table1_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.DOC by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  4. 8404

    Image3_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.JPEG by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  5. 8405

    Table2_Efficacy and safety of guanxinshutong capsule combined with western medicine on stable angina pectoris: a systematic review and meta-analysis.DOC by Liyuan Yu (5341841)

    Published 2024
    “…GXST and WM combination was significantly more effective than WM alone across several metrics: clinical efficacy rate (odds ratio [OR] = 4.05, 95% confidence interval [CI] = 3.42–4.80), electrocardiogram improvement (OR = 3.39, 95% CI = 2.35–4.87), enhancement in left ventricular ejection fraction (mean difference [MD] = 1.07, 95% CI = 0.69–1.46), reduction in total cholesterol levels (MD = −0.78, 95% CI = −1.20 to −0.35), decrease in tumor necrosis factor-alpha (MD = −1.36, 95% CI = −2.18 to −0.53), and improvement in Chinese medicine evidence score (OR = 3.77, 95% CI = 2.20–6.43). …”
  6. 8406

    Engineered deletions of 1-TbAd biosynthesis genes reveal gene functions and greatly expand the lipid signature. by Jacob A. Mayfield (19762468)

    Published 2024
    “…(B) Area-under-the-curve of extracted ion chromatograms tested 1-TbAd production by the parental Mtb strain (H37Rv) and single or two-gene knockouts as well as the <i>Rv3378c</i> deletion complemented with <i>Rv3378c</i>. A Benjamini–Hochberg adjusted <i>p</i> value is indicated only for significant pairwise <i>t</i> tests (*: <i>p</i> < 0.05, **: <i>p</i> < 0.01, ***: <i>p</i> < 0.001, ****: <i>p</i> < 0.0001). …”
  7. 8407

    Raw data for Figs 1, 2, 3, 4 and S2. by Areej A. Alfaifi (20422411)

    Published 2024
    “…Bulk RNA-sequencing of parotid salivary glands from COVID-19 autopsies demonstrated statistically significant decreased expression of histatin and amylase genes. …”
  8. 8408

    Data Sheet 1_Plasma testosterone concentration is correlated with circulating immune cell abundance in transgender young people on gender-affirming hormone treatment.pdf by Alice A. White (21695726)

    Published 2025
    “…Differences in the abundance of other T cell subsets were detected in both trans males and trans females, however only a decrease in CD161<sup>+</sup> T effector memory cells in trans males, compared to control females, was associated with lower testosterone levels. …”
  9. 8409

    Vinpocetine improves survival rate in DENA-exposed rats. by Osama A. Mohammed (18548092)

    Published 2024
    “…<p>The administration of DENA led to a gradual decrease in rats’ survival over the experimental period. …”
  10. 8410

    GRADE judgements. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  11. 8411

    Basic characteristics of the included studies. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  12. 8412

    The data of meta-analysis. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  13. 8413

    Risk of bias. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  14. 8414

    Overall risk of bias assessment. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  15. 8415

    Funnel plot of VO<sub>2Peak</sub> inclusion studies. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  16. 8416

    Analysis of subgroups. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  17. 8417

    Multiple comparisons after ANOVA(CR10). by Xinyu Dai (5100731)

    Published 2025
    “…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”
  18. 8418

    Homogeneity test of CR10. by Xinyu Dai (5100731)

    Published 2025
    “…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”
  19. 8419

    Illustration of the fNIRS device worn. by Xinyu Dai (5100731)

    Published 2025
    “…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”
  20. 8420

    Analysis of variance of HbO<sub>2</sub> in bilateral PFC. by Xinyu Dai (5100731)

    Published 2025
    “…</p><p>Results</p><p>Following the intervention, a significant difference in CR10 was observed between the various groups. …”